GYRE
NASDAQ HealthcareGyre Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $7.80 |
|---|---|
| Volume | 202,645 |
| Market Cap | 751.88M |
| Beta | 6.920 |
| RSI (14-Day) | 44.8 |
| 200-Day MA | $7.80 |
| 50-Day MA | $7.92 |
| 52-Week High | $12.62 |
| 52-Week Low | $6.11 |
| P/E Ratio | 195.12 |
| Forward P/E | 130.08 |
| Price / Book | 6.96 |
🎯 Investment Strategy Scores
How GYRE scores across each investment strategy. Higher is better for that strategy's goals.
🚀 Moon Shot
99/100
High growth potential (high beta + oversold)
🔪 Falling Knife
40/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
63/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
20/100
Large-cap, institutional-quality stocks
Find GYRE in your text
Paste any text on the homepage — the tool will extract GYRE and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.